Janssen Therap Company Profile
✉ Email this page to a colleague
What is the competitive landscape for JANSSEN THERAP, and what generic alternatives to JANSSEN THERAP drugs are available?
JANSSEN THERAP has one approved drug.
There are two US patents protecting JANSSEN THERAP drugs.
There are eighty-seven patent family members on JANSSEN THERAP drugs in thirty-nine countries and eighteen supplementary protection certificates in fifteen countries.
Drugs and US Patents for Janssen Therap
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Therap | SIRTURO | bedaquiline fumarate | TABLET;ORAL | 204384-001 | Dec 28, 2012 | RX | Yes | Yes | 7,498,343 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Janssen Therap | SIRTURO | bedaquiline fumarate | TABLET;ORAL | 204384-002 | May 27, 2020 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Janssen Therap | SIRTURO | bedaquiline fumarate | TABLET;ORAL | 204384-001 | Dec 28, 2012 | RX | Yes | Yes | 8,546,428 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Janssen Therap | SIRTURO | bedaquiline fumarate | TABLET;ORAL | 204384-002 | May 27, 2020 | RX | Yes | No | 8,546,428 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Janssen Therap Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Poland | 222801 | ⤷ Try a Trial |
Germany | 60332023 | ⤷ Try a Trial |
Taiwan | 200838527 | ⤷ Try a Trial |
Norway | 329935 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Janssen Therap Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1527050 | 132014902288493 | Italy | ⤷ Try a Trial | PRODUCT NAME: BEDAQUILINA O UN SUO SALE DI ADDIZIONE DI ACIDO O BASE FARMACEUTICAMENTE ACCETTABILE INCLUSO BEDAQUILINA FUMARATO(SIRTURO); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/13/901, 20140305 |
1527050 | 2014/045 | Ireland | ⤷ Try a Trial | PRODUCT NAME: BEDAQUILINE, OR A PHARMACEUTICALLY ACCEPTABLE ACID OR BASE ADDITION SALT THEREOF, INCLUDING BEDAQUILINE FUMARATE; REGISTRATION NO/DATE: EU/1/13/901 20140305 |
1527050 | 50/2014 | Austria | ⤷ Try a Trial | PRODUCT NAME: BEDAQUILIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SAEURE- ODER BASENADDITIONSSALZ DAVON, EINSCHLIESSLICH BEDAQUILINFUMARAT; REGISTRATION NO/DATE: EU/1/13/901 20140307 |
1527050 | C20140026 00112 | Estonia | ⤷ Try a Trial | PRODUCT NAME: BEDAKVILIIN;REG NO/DATE: K(2014)1616 (LOPLIK) 07.03.2014 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.